WALTHAM, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics, Inc. [NYSE MKT: CVRS], a leading developer of precision vascular robotics, announced today a strategic partnership with BLOXR Solutions, a leading provider of radiation protection products designed to reduce exposure for clinicians and patients. The three-year distribution agreement grants Corindus the non-exclusive rights to distribute BLOXR's radiation protection products globally and provides BLOXR with additional reach into the interventional cardiology space. Under the agreement, Corindus may sell the entire BLOXR line, which offers multiple types of protective equipment including aprons, thyroid collars and caps.
“Protecting the physicians and staff who care for patients every day is an important part of our mission,” said Mark Toland, President and Chief Executive Officer of Corindus. “We are excited to partner with BLOXR to offer complementary radiation protection products for our cath lab customers around the world.”
Corindus' CorPath® System, the first robotic-assisted PCI platform cleared by the FDA, has been shown* to reduce radiation exposure to the primary operator by 95%1 by positioning them behind a radiation-shielded interventional workstation. Clinical trials with the CorPath System* have also shown a 15%2 reduction in radiation exposure for cath lab staff, which can potentially be further enhanced by the addition of the BLOXR line of lightweight protective apparel. BLOXR® XPF® apparel, which has the potential to further reduce the orthopedic burden for these critical team members, is a patented, comfortable, lightweight material that can be bent and folded without cracking, provides 0.5mm lead equivalent protection and is guaranteed for three years.
“In keeping with our focus of bringing innovation to radiation protection, BLOXR Solutions is excited to make this strategic partnership with Corindus,” said Julia Jacobson, President and CEO of BLOXR Solutions. “Together, we believe we can greatly improve the quality of life for interventional teams by reducing dose exposure, increasing radiation safety, and improving wellness by lessening the potential for occupational injury.”
About Corindus Vascular Robotics
Corindus Vascular Robotics, Inc. is a global technology leader in robotic-assisted vascular interventions. The company's CorPath® System is the first FDA-cleared medical device to bring robotic precision to interventional procedures. During the procedure, the interventional cardiologist sits at a radiation-shielded workstation to advance guide catheters, stents, and guidewires with millimeter-by-millimeter precision. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries. With the CorPath System, Corindus Vascular Robotics brings robotic precision to interventional procedures to help optimize clinical outcomes and minimize the costs associated with complications of improper stent placement during manual procedures. Corindus stands behind its product with its unique $1,000 hospital credit "One Stent Program." For additional information, visit www.corindus.com, and follow @CorindusInc.
About BLOXR Solutions
BLOXR Solutions, LLC is a leading provider of radiation protection products designed to reduce exposure for clinicians and patients through innovative applications of its proprietary technologies. BLOXR® XPF® Technology provides the foundation for a complete line of safer, greener, lighter radiation protection apparel, cream and shielding products for medical and industrial applications. ULTRABLOX® X-Ray Attenuation Cream is the only topical product available to provide effective scatter radiation protection of a clinician's hands during radiological procedures, without affecting dexterity and tactile feel. XPF garments allow clinicians to wear a lightweight alternative to lead and like-lead products with effective protection against scatter radiation.
